Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

52 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Isodose surface volumes in cervix cancer brachytherapy: Change of practice from standard (Point A) to individualized image guided adaptive (EMBRACE I) brachytherapy.
Serban M, Kirisits C, Pötter R, de Leeuw A, Nkiwane K, Dumas I, Nesvacil N, Swamidas J, Hudej R, Lowe G, Hellebust TP, Menon G, Oinam A, Bownes P, Oosterveld B, De Brabandere M, Koedooder K, Marthinsen ABL, Lindegaard J, Tanderup K; EMBRACE Collaborative Group. Serban M, et al. Among authors: swamidas j. Radiother Oncol. 2018 Dec;129(3):567-574. doi: 10.1016/j.radonc.2018.09.002. Epub 2018 Sep 19. Radiother Oncol. 2018. PMID: 30243671
Reporting and validation of gynaecological Groupe Euopeen de Curietherapie European Society for Therapeutic Radiology and Oncology (ESTRO) brachytherapy recommendations for MR image-based dose volume parameters and clinical outcome with high dose-rate brachytherapy in cervical cancers: a single-institution initial experience.
Mahantshetty U, Swamidas J, Khanna N, Engineer R, Merchant NH, Deshpande DD, Shrivastava S. Mahantshetty U, et al. Among authors: swamidas j. Int J Gynecol Cancer. 2011 Aug;21(6):1110-6. doi: 10.1097/IGC.0b013e31821caa55. Int J Gynecol Cancer. 2011. PMID: 21633296
Late rectal toxicity after image-based high-dose-rate interstitial brachytherapy for postoperative recurrent and/or residual cervical cancers: EQD2 predictors for Grade ≥II toxicity.
Chopra S, Dora T, Engineer R, Mechanery S, Agarwal P, Kannan S, Ghadi Y, Swamidas J, Mahantshetty U, Shrivastava SK. Chopra S, et al. Among authors: swamidas j. Brachytherapy. 2015 Nov-Dec;14(6):881-8. doi: 10.1016/j.brachy.2015.08.007. Epub 2015 Sep 26. Brachytherapy. 2015. PMID: 26409708
Multicentre evaluation of a novel vaginal dose reporting method in 153 cervical cancer patients.
Westerveld H, de Leeuw A, Kirchheiner K, Dankulchai P, Oosterveld B, Oinam A, Hudej R, Swamidas J, Lindegaard J, Tanderup K, Pötter R, Kirisits C; EMBRACE Collaborative Group. Westerveld H, et al. Among authors: swamidas j. Radiother Oncol. 2016 Sep;120(3):420-427. doi: 10.1016/j.radonc.2016.05.002. Epub 2016 May 26. Radiother Oncol. 2016. PMID: 27237058
Standard Chemoradiation and Conventional Brachytherapy for Locally Advanced Cervical Cancer: Is It Still Applicable in the Era of Magnetic Resonance-Based Brachytherapy?
Mittal P, Chopra S, Pant S, Mahantshetty U, Engineer R, Ghosh J, Gupta S, Ghadi Y, Menachery S, Swamidas J, Gurram L, Shrivastava SK. Mittal P, et al. Among authors: swamidas j. J Glob Oncol. 2018 Jul;4:1-9. doi: 10.1200/JGO.18.00028. J Glob Oncol. 2018. PMID: 30085892 Free PMC article.
Acute hematological toxicity during post-operative bowel sparing image-guided intensity modulated radiation with concurrent cisplatin.
Lewis S, Chopra S, Naga P, Pant S, Dandpani E, Bharadwaj N, Mahantshetty U, Engineer R, Swamidas J, Ghosh J, Gupta S, Shrivastava S. Lewis S, et al. Among authors: swamidas j. Br J Radiol. 2018 Dec;91(1092):20180005. doi: 10.1259/bjr.20180005. Epub 2018 Oct 3. Br J Radiol. 2018. PMID: 30179056 Free PMC article. Clinical Trial.
52 results